Professor Emeritus of Internal Medicine
Professor Emeritus of Molecular and Integrative Physiology
[email protected]
Available to mentor
Stevo Julius
Professor Emeritus/a
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
-
Vrsalovic M, Heimark S, Søraas CL, Mehlum MH, Kjeldsen SE, Mancia G, Julius S, Weber MA. Hypertension, 2024 Jul; 81 (7): 1628 - 1636.Journal ArticleCardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial.
DOI:10.1161/HYPERTENSIONAHA.124.22832 PMID: 38716657 -
Rist A, Sevre K, Wachtell K, Devereux RB, Aurigemma GP, Smiseth OA, Kjeldsen SE, Julius S, Pitt B, Burnier M, Kreutz R, Oparil S, Mancia G, Zannad F. Eur J Intern Med, 2024 Feb; 120: 3 - 10.Journal ArticleThe current best drug treatment for hypertensive heart failure with preserved ejection fraction.
DOI:10.1016/j.ejim.2023.10.008 PMID: 37865559 -
Sevre K, Rist A, Wachtell K, Devereux RB, Aurigemma GP, Smiseth OA, Kjeldsen SE, Julius S, Pitt B, Burnier M, Kreutz R, Oparil S, Mancia G, Zannad F. Am J Hypertens, 2024 Jan 1; 37 (1): 1 - 14.Journal ArticleWhat Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence.
DOI:10.1093/ajh/hpad073 PMID: 37551929 -
Heimark S, Mehlum MH, Mancia G, Søraas CL, Liestøl K, Wachtell K, Larstorp AC, Rostrup M, Mariampillai JE, Kjeldsen SE, Julius S, Weber MA. Hypertension, 2023 Aug; 80 (8): 1739 - 1748.Journal ArticleMiddle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg.
DOI:10.1161/HYPERTENSIONAHA.123.21454 PMID: 37350267 -
Nazarzadeh M, Bidel Z, Canoy D, Copland E, Bennett DA, Dehghan A, Davey Smith G, Holman RR, Woodward M, Gupta A, Adler AI, Wamil M, Sattar N, Cushman WC, McManus RJ, Teo K, Davis BR, Chalmers J, Pepine CJ, Rahimi K, Blood Pressure Lowering Treatment Trialists' Collaboration . Lancet Diabetes Endocrinol, 2022 Sep; 10 (9): 645 - 654.Journal ArticleBlood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
DOI:10.1016/S2213-8587(22)00172-3 PMID: 35878651 -
Lilja-Cyron A, Bang CN, Gerdts E, Larstorp AC, Kjeldsen SE, Julius S, Okin PM, Wachtell K, Devereux RB. Rev Cardiovasc Med, 2022 Mar 10; 23 (3): 95Journal ArticleAortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life Study.
DOI:10.31083/j.rcm2303095 PMID: 35345262 -
Chinali M, Aurigemma GP, Gerdts E, Wachtell K, Okin PM, Muthiah A, Kjeldsen SE, Julius S, de Simone G, Devereux RB. Exploration of Medicine, 2022 Jan 1; 3 (2): 160 - 172.Journal ArticleDevelopment of systolic dysfunction unrelated to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy. The LIFE Study
DOI:10.37349/emed.2022.00082 -
Alegria W, Marini BL, Gregg KS, Bixby DL, Perissinotti A, Nagel J, Hudetz AG, Pearce RA. Journal of the National Comprehensive Cancer Network : JNCCN, 2022 Jan 1; 10.6004/jnccn.2021.7054: 1 - 8.Journal ArticleEarly Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.
